Literature DB >> 10496532

Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.

G P Nielsen1, A O Stemmer-Rachamimov, J Shaw, J E Roy, J Koh, D N Louis.   

Abstract

p16INK4A is a cell cycle inhibitor that is commonly inactivated in human tumors and tumor cell lines. Despite its importance in human neoplasia, the normal pattern of p16 expression remains largely unknown. Therefore, we analyzed the immunohistochemical localization of p16 in all human organs and demonstrated that cellular p16 expression is highly selective. In adults, proliferative endometrium, breast ductal epithelium, squamous and tubal metaplastic epithelium of the uterine cervix, esophageal squamous epithelium, salivary glands, and antral gastric glands all strongly express the protein. p16 is also widely expressed in endocrine glands, including Langerhans cells in the pancreas and anterior pituicytes and Leydig and Sertoli cells in testis. Within each tissue, however, p16 expression does not correlate with cellular proliferation or maturation. In infants, p16 staining was limited to thymic Hassall's corpuscles, occasional thymic lymphocytes, and only rare pancreatic epithelial cells. Therefore, increased expression of p16 in adult tissues, as in mouse tissues, may reflect a role of p16 in cellular senescence. Restriction of p16 expression in infants to the thymus, the only organ committed to early senescence, is also consistent with such a role. Documentation of the pattern of p16 expression in normal tissues will contribute to our understanding of the normal function of this protein and to interpretation of potentially altered p16 expression in human tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10496532

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  67 in total

1.  p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages.

Authors:  Céline Cudejko; Kristiaan Wouters; Lucía Fuentes; Sarah Anissa Hannou; Charlotte Paquet; Kadiombo Bantubungi; Emmanuel Bouchaert; Jonathan Vanhoutte; Sébastien Fleury; Patrick Remy; Anne Tailleux; Giulia Chinetti-Gbaguidi; David Dombrowicz; Bart Staels; Réjane Paumelle
Journal:  Blood       Date:  2011-06-02       Impact factor: 22.113

2.  Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer.

Authors:  Hanna K Sanoff; Allison M Deal; Janakiraman Krishnamurthy; Chad Torrice; Patrick Dillon; Jessica Sorrentino; Joseph G Ibrahim; Trevor A Jolly; Grant Williams; Lisa A Carey; Amy Drobish; Brittaney-Belle Gordon; Shani Alston; Arti Hurria; Karin Kleinhans; K Lenhard Rudolph; Norman E Sharpless; Hyman B Muss
Journal:  J Natl Cancer Inst       Date:  2014-03-28       Impact factor: 13.506

3.  Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

Authors:  G P Nielsen; A O Stemmer-Rachamimov; Y Ino; M B Moller; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

4.  Ionizing radiation-induced long-term expression of senescence markers in mice is independent of p53 and immune status.

Authors:  Oanh N L Le; Francis Rodier; Francois Fontaine; Jean-Philippe Coppe; Judith Campisi; James DeGregori; Caroline Laverdière; Victor Kokta; Elie Haddad; Christian M Beauséjour
Journal:  Aging Cell       Date:  2010-03-13       Impact factor: 9.304

5.  A keratinocyte hypermotility/growth-arrest response involving laminin 5 and p16INK4A activated in wound healing and senescence.

Authors:  Easwar Natarajan; John D Omobono; Zongyou Guo; Susan Hopkinson; Alexander J F Lazar; Thomas Brenn; Jonathan C Jones; James G Rheinwald
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

6.  A quantitative model for age-dependent expression of the p16INK4a tumor suppressor.

Authors:  Denis Tsygankov; Yan Liu; Hanna K Sanoff; Norman E Sharpless; Timothy C Elston
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-14       Impact factor: 11.205

7.  Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.

Authors:  Jean-Philippe Coppé; Francis Rodier; Christopher K Patil; Adam Freund; Pierre-Yves Desprez; Judith Campisi
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

8.  p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.

Authors:  Aharon Helman; Agnes Klochendler; Narmen Azazmeh; Yael Gabai; Elad Horwitz; Shira Anzi; Avital Swisa; Reba Condiotti; Roy Z Granit; Yuval Nevo; Yaakov Fixler; Dorin Shreibman; Amit Zamir; Sharona Tornovsky-Babeay; Chunhua Dai; Benjamin Glaser; Alvin C Powers; A M James Shapiro; Mark A Magnuson; Yuval Dor; Ittai Ben-Porath
Journal:  Nat Med       Date:  2016-03-07       Impact factor: 53.440

9.  p16 expression in squamous lesions of the female genital tract.

Authors:  Mary M Finegan; Aaron C Han; Mitchell I Edelson; Norman G Rosenblum
Journal:  J Mol Histol       Date:  2004-02       Impact factor: 2.611

10.  Aging and cancer resistance in lymphoid progenitors are linked processes conferred by p16Ink4a and Arf.

Authors:  Robert A J Signer; Encarnacion Montecino-Rodriguez; Owen N Witte; Kenneth Dorshkind
Journal:  Genes Dev       Date:  2008-11-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.